Related Experiment Video

Updated: Jul 15, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Current update of pediatric hepatitis vaccine use

S Malay1, K Tizer, L I Lutwick

  • 1Department of Pediatrics, SUNY-Health Science Center at Brooklyn, USA.

Pediatric Clinics of North America
|April 13, 2000
PubMed

Insights

New vaccines for hepatitis A and B are available, with a focus on pediatric use. The article reviews 1999 issues, including US hepatitis A vaccine recommendations and hepatitis B vaccine safety concerns.

Area of Science:

  • Pediatric medicine
  • Immunology
  • Vaccinology

Background:

  • Hepatitis A and B vaccines are crucial for disease prevention.
  • Pediatric vaccination is a key public health strategy.
  • Recent developments in vaccine recommendations and safety are important.

Purpose of the Study:

  • To review available hepatitis A and B vaccines.
  • To focus on the use of these biologics in pediatric patients.
  • To discuss significant issues and changes in 1999.

Main Methods:

  • Literature review of vaccine data.
  • Analysis of US recommendations for hepatitis A vaccine.
  • Examination of safety data and concerns for hepatitis B vaccine.

Main Results:

  • Hepatitis A vaccine recommendations changed in the US for higher-risk areas.
  • Concerns regarding the safety of hepatitis B vaccine were noted.
  • The review highlights the importance of updated vaccine information for pediatric care.

Conclusions:

  • Hepatitis A and B vaccines are vital tools for preventing viral hepatitis.
  • Pediatricians must stay informed about vaccine updates and safety profiles.
  • Continued vigilance and evidence-based practice are essential in vaccinology.

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...